The healthcare industry is shifting towards a precision-based treatment model. NuView Life Sciences is at the forefront of the effort to develop new, targeted cancer…
Read More
Inaccurate and unnecessary cancer screening tests cost the U.S. healthcare system billions of dollars each year. New screening tools in development by NuView Life Science…
The recent shutdown of a major radioisotope production facility will potentially cause shortages of a vital medical isotope used worldwide in nuclear medicine procedures. US…
Traditional cancer diagnostic methods, including biopsies, are labor-intensive, expensive and invasive. NVLS is poised to change the way cancer is diagnosed with its new liquid…
